TWA
ABBV icon

TCI Wealth Advisors’s AbbVie ABBV Stock Holding History

TCI Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,500
Closed -$487K – 2299
2021
Q1 		$487K Sell
4,500
-5,500
-55% -$588K 0.21% 99
2020
Q4 		$1.07M Buy
10,000
+5,000
+100% +$480K 0.48% 50
2020
Q3 		$438K Buy
+5,000
New +$471K 0.17% 97

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

TCI Wealth Advisors's ABBV Position: Q2 2026 in Review

TCI Wealth Advisors increased its AbbVie (ABBV) stake by 1.8% in Q2 2026, buying an estimated $57.7K and bringing the position to 15,431 shares worth $3.88M. The position accounts for 0.17% of the portfolio, ranked #52.

TCI Wealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TCI Wealth Advisors held 15,431 shares of AbbVie worth $3.88M as of Q2 2026.
  • TCI Wealth Advisors bought 268 AbbVie shares in Q2 2026, an estimated $57.7K.
  • AbbVie made up 0.17% of TCI Wealth Advisors's portfolio in Q2 2026, its #52 holding.
  • TCI Wealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TCI Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.